当前位置: X-MOL首页全球导师 国内导师 › 康贵峰

个人简介

姓名:康贵峰 性别:男 职称:讲师 2016年进入多肽及小分子药物北京市重点实验室,任药物化学系讲师。讲授课程包括药物化学、有机化学、药物的波谱解析实验、专业药学实验等。 教育经历 2005/8-2008/7,北京大学药学院,博士,导师:彭师奇、赵明。 2002/9-2005/7,中国科学院山西煤化所,硕士,导师:王建国。 1998/9-2002/7,西北大学化学系,学士。 工作经历 2016/1-至今,首都医科大学化学生物学院药学院,教师 2014/9-2015/12,美国弗吉尼亚联邦大学药物化学系,博士后 2012/4-2013/11,北京四环制药,项目经理 2009/12-2014/1,浙江大学、浙江医药股份有限公司新昌制药厂联合培养,博士后 2009/12-2012/3,浙江医药股份有限公司新昌制药厂,职工 2008/9-2009/10,康龙化成(北京)新药技术有限公司,高级研究员

研究领域

药物化学,有机化学杂环小分子的设计、合成、活性评价及作用机制研究

近期论文

查看导师新发文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

1.GuifengKang,YujiWang,JiawangLiu,JianhuiWu,MingZhao,GuochunLi,NingLi,LiPeng,XiaoyiZhang,LiLi,NathanMair,ShiqiPeng,Developmentofthree-componentconjugates:togetnano-globeswithpououssurfaces,highinvivoanti-osteoporosisactivityandminimalsideeffects,J.Mater.Chem.,09/2012,22(40),21740-21748. 2.GuifengKang,MingZhao,XiaoyiZhang,LiPeng,ChunboLi,WeiMao,WeidongYe,ShiqiPeng“AclassofnovelconjugatesofsubstitutedpurineandGly-AA-OBzl:Synthesisandevaluationoforallyanalgesicactivity”,Bioorg.Med.Chem.Lett.,10/2010,20(20),6157-6160. 3.YujiWang,GuifengKang,JiawangLiu,MingZhao,JianhuiWu,XiaoyiZhang,YeLi,XiaoboZhong,YifanYang,ShiqiPeng,NovelpotassiumN-[(2S,3R,4R,5R)-2,3,4,5,6-pentahy-droxylhex-1-yl]-L-aminoaciddichloroplatinates(II)withhighanti-tumoractivityandlowsidereaction,Metallomics,04/2012,4(5),441-447. 4.JinghuaZhao,GuifengKang,WeiWang,MingZhao,XiaoyiZhang,ChunboLu,WeiMao,HengWeiChang,WeidongYe,ShiqiPeng,N-[2-Chloro-9H-purin-6-yl]-N-cyclopropylgly-cylaminoacidsandderivatives:Synthesis,evaluationasaclassofnovelanalgesics,and3DQSARanalysis,Bioorg.Med.Chem.,08/2009,17(17),6305-6310. 5.YujiWang,GuifengKang,MingZhao,JianhuiWu,XiaoyiZhang,YifanYang,JiawangLiu,ShiqiPeng,Anewplatinum-complexshoweasypreparation,promisinganti-tumoractivity,andbetterefficacyanddistributionpropertiesthanoxaliplatin,Mol.BioSyst.,12/2011,7(12),3245-3252. 6.NingLi,GuifengKang,LinGui,MingZhao,WenjingWang,JianweiZhang,Yan-FengYue,ShiqiPeng,NovelCu(II)-RGD-octapeptides:Synthesis,coordinationmode,invitroanti-plateletaggregation/invivoanti-thromboticevaluationandcorrelationofsequencewithnano-structure.,Nanomed-Nanotechnol.,01/2011,7(4),403-409. 7.YujiWang,JianhuiWu,GuifengKang,MingZhao,LinGui,NingLi,LiPeng,XiaoyiZhang,LiLi,ShiqiPeng,Novelnano-materialsRGD-tetrapeptide-modified17β-amino-11α-hydroxyandrost-1,4-diene-3-one:synthesis,self-assemblybasednano-imagesandinvivoanti-osteoporosisevaluation,J.Mater.Chem.,02/2012,22(11),4652-4659. 8.YujiWang,JianhuiWu,GuifengKang,MingZhao,LinGui,NingLi,LiPeng,XiaoyiZhang,LiLi,ShiqiPeng,Novelnano-materialsRGD-tetrapeptide-modified17β-amino-11α-hydroxyandrost-1,4-diene-3-one:synthesis,self-assemblybasednano-imagesandinvivoanti-osteoporosisevaluation,J.Mater.Chem.,02/2012,22(11),4652-4659. 9.JingchengTang,MingZhao,YujiWang,GuifengKang,JianhuiWu,MeiqingZheng,ShiqiPeng,OnesingleHPLC-PDA/(-)ESI-MS/MSanalysistosimultaneouslydetermine30componentsoftheaqueousextractofRabdosiarubescens,J.Chromatogr.B.,09/2011,879(26)2783-2793. 10.JianhuiWu,LeiWei,MingZhao,YujiWang,GuifengKang,ShiqiPeng,N-[2(3-Carboxyl-9-benzyl-carboline-1-yl)ethyl-1-yl]-aminoacids:correlationofspectralpropertywithinvivoanti-tumoractivity,Med.Chem.Res.,04/2012,21(1),116-123. 11.WenjingWang,MingZhao,YujiWang,JiawangLiu,JianhuiWu,GuifengKangandShiqiPeng,{2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-aceticacidmethylester(MIAM):Itsanti-cancerefficacyandintercalationmechanismidentifiedviamulti-modelsystems,Mol.BioSyst.,03/2011,7(3),766-772.

推荐链接
down
wechat
bug